Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Manegold

Showing results (141-150 of 177) with videos related to

Pageof 18
Sort By:
British Journal of Cancer|June 24, 2010
Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experienceP Ströbel, R Bargou, A Wolff, et al.
Deutsche Medizinische Wochenschrift (1946)|December 12, 1986
[Therapy of stomach ulcer with sucralfate and ranitidine. A multicenter double-blind study]A L Blum, J C Bode, W Domschke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2010
Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)M Reck, J von Pawel, P Zatloukal, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOPB Steinke, K Bross, H M Reinold, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2008
Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agentG Carteni, C Manegold, G Martin Garcia, et al.
Investigational New Drugs|July 30, 1999
Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusionI Rassmann, R Thödtmann, M Mross, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
A phase II EORTC study of temozolomide in patients with malignant pleural mesotheliomaJ P van Meerbeeck, P Baas, C Debruyne, et al.
Klinische Wochenschrift|May 16, 1980
[Renal osteodystrophy in children. Therapy with 1,25-dihydroxy-cholechalciferol (author's transl)]M Bulla, G Delling, G Benz-Bohm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts PanelC Gridelli, A Ardizzoni, T Le Chevalier, et al.
Pharmacogenetics and Genomics|November 7, 2008
Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancerGeorg Lurje, Andrew E Hendifar, Anne M Schultheis, et al.
Pageof 18

Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
British Journal of Cancer|June 24, 2010
Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experienceP Ströbel, R Bargou, A Wolff, et al.
Deutsche Medizinische Wochenschrift (1946)|December 12, 1986
[Therapy of stomach ulcer with sucralfate and ranitidine. A multicenter double-blind study]A L Blum, J C Bode, W Domschke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2010
Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)M Reck, J von Pawel, P Zatloukal, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOPB Steinke, K Bross, H M Reinold, et al.
Lung Cancer (Amsterdam, Netherlands)|December 2, 2008
Malignant peritoneal mesothelioma-Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agentG Carteni, C Manegold, G Martin Garcia, et al.
Investigational New Drugs|July 30, 1999
Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusionI Rassmann, R Thödtmann, M Mross, et al.
European Journal of Cancer (Oxford, England : 1990)|April 9, 2002
A phase II EORTC study of temozolomide in patients with malignant pleural mesotheliomaJ P van Meerbeeck, P Baas, C Debruyne, et al.
Klinische Wochenschrift|May 16, 1980
[Renal osteodystrophy in children. Therapy with 1,25-dihydroxy-cholechalciferol (author's transl)]M Bulla, G Delling, G Benz-Bohm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts PanelC Gridelli, A Ardizzoni, T Le Chevalier, et al.
Pharmacogenetics and Genomics|November 7, 2008
Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancerGeorg Lurje, Andrew E Hendifar, Anne M Schultheis, et al.
Pageof 18